Epicardial Adipose Tissue: A Potential Target to Improve Left Ventricular Diastolic Dysfunction

Area of Science:

• Cardiology
• Biomedical Engineering
• Physiology

Background:

• Left ventricular diastolic dysfunction (LVDD) is a precursor to heart failure, significantly impacting quality of life and mortality.
• Accurate diagnosis and treatment of LVDD necessitate a deep understanding of its underlying pathogenesis.
• Echocardiography and cardiac magnetic resonance are key imaging techniques for assessing left ventricular diastolic function.

Purpose of the Study:

• To review recent advancements in the clinical evaluation of LVDD.
• To elucidate the pathophysiological role of epicardial adipose tissue (EAT) in LVDD.
• To explore the therapeutic potential of targeting EAT for LVDD management.

Main Methods:

• Literature review of recent studies on LVDD and EAT.
• Analysis of clinical data correlating EAT with LVDD in various conditions.
• Evaluation of therapeutic interventions targeting EAT and their impact on diastolic function.

Main Results:

• Increased EAT is consistently correlated with LVDD across diverse clinical settings, including hypertension, coronary artery disease, diabetes, and obesity.
• Interventions aimed at reducing EAT, such as medications, lifestyle changes, and bariatric surgery, have shown promise in improving diastolic parameters.
• These EAT-reducing strategies appear to concurrently enhance diastolic function restoration.

Conclusions:

• Epicardial adipose tissue plays a significant role in the pathophysiology of LVDD.
• Targeting EAT reduction presents a promising therapeutic strategy for managing LVDD and potentially preventing heart failure progression.
• Further research into EAT-focused interventions could lead to improved clinical outcomes for patients with diastolic dysfunction.